Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Johan Richter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response
Warfvinge, R., Geironson Ulfsson, L., Dhapola, P., Safi, F., Sommarin, M., Soneji, S., Hjorth-Hansen, H., Mustjoki, S., Richter, J., Thakur, R. K. & Karlsson, G., 2024 Nov 6, In: eLife. 12Research output: Contribution to journal › Article › peer-review
Open Access -
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study
Dahlén, T., Edgren, G., Ljungman, P., Flygt, H., Richter, J., Olsson-Strömberg, U., Wadenvik, H., Dreimane, A., Myhr-Eriksson, K., Zhao, J., Själander, A., Höglund, M. & Stenke, L., 2022, In: American Journal of Hematology. 97, 4, p. 421-430 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Gene therapy for infantile malignant osteopetrosis: review of pre-clinical research and proof-of-concept for phenotypic reversal
Moscatelli, I., Almarza, E., Schambach, A., Ricks, D., Schulz, A., Herzog, C. D., Henriksen, K., Askmyr, M., Schwartz, J. D. & Richter, J., 2021, In: Molecular Therapy - Methods and Clinical Development. 20, p. 389-397 9 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study
Flygt, H., Söderlund, S., Stentoft, J., Richter, J., Koskenvesa, P., Mustjoki, S., Majeed, W., Lübking, A., Dreimane, A., Markevärn, B., Stenke, L., Myhr Eriksson, K., Gjertsen, B. T., Gedde-Dahl, T., Dimitrijevic, A., Udby, L., Olsson-Strömberg, U. & Hjorth-Hansen, H., 2021, In: European Journal of Haematology. 107, 6, p. 617-623Research output: Contribution to journal › Article › peer-review
Open Access -
Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population-based Swedish chronic myeloid leukaemia registry
Flygt, H., Sandin, F., Dahlén, T., Dremaine, A., Lübking, A., Markevärn, B., Myhr-Eriksson, K., Olsson, K., Olsson-Strömberg, U., Själander, A., Söderlund, S., Wennström, L., Wadenvik, H., Stenke, L., Höglund, M. & Richter, J., 2021, In: British Journal of Haematology. 193, 5, p. 915-921Research output: Contribution to journal › Article › peer-review
Open Access
-
Red blood cell devlopment and novel mechanism to treat refractory anemia
Sen, T. (PI), Singbrant, S. (Supervisor), Richter, J. (Assistant supervisor) & Flygare, J. (PI)
2016/04/01 → …
Project: Dissertation
-
Improving our understanding of osteoclasts in bone metabolic diseases through novel osteoclast models
Löfvall, H. (Research student), Richter, J. (Supervisor), Henriksen, K. (Assistant supervisor) & Thudium, C. S. (Assistant supervisor)
2014/07/15 → 2018/10/31
Project: Research